Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating activities:    
Consolidated net income $ 423.5 $ 370.3
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 216.7 195.4
Stock-based compensation expense 34.6 30.2
Excess tax benefits from stock-based compensation plans 0.0 (29.6)
Deferred income taxes (40.6) (10.4)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (14.9) (54.5)
Other assets, current and long-term (24.4) (0.9)
Current and long term liabilities, excluding debt 13.8 43.7
Cash provided by operating activities 608.7 544.2
Investing activities:    
Capital expenditures (157.5) (131.0)
Acquisitions, net of cash acquired (77.3) (1,792.4)
Economic hedges 0.0 (10.8)
Cash received from sale of asset 8.6 0.0
Cash used in investing activities (226.2) (1,934.2)
Financing activities:    
Net short-term borrowings 354.9 194.2
Payments on long-term debt (322.5) (300.0)
Borrowings on long-term debt 0.0 1,574.7
Treasury stock purchases (77.1) 0.0
Dividends paid to Equifax shareholders (140.7) (118.1)
Dividends paid to noncontrolling interests (8.2) (5.8)
Proceeds from exercise of stock options 18.8 26.8
Payment of taxes related to settlement of equity awards (28.0) (19.7)
Excess tax benefits from stock-based compensation plans 0.0 29.6
Purchase of redeemable noncontrolling interests 0.0 (3.6)
Other 0.0 (5.4)
Cash (used in) provided by financing activities (202.8) 1,372.7
Effect of foreign currency exchange rates on cash and cash equivalents 6.4 35.5
Increase in cash and cash equivalents 186.1 18.2
Cash and cash equivalents, beginning of period 129.3 93.3
Cash and cash equivalents, end of period $ 315.4 $ 111.5